Catalyst Wire Dossier Catalyst Wire Dossier

ROSUVASTATIN CALCIUM

rosuvastatin calcium · Cadila Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

55 regulatory and trial events tracked for ROSUVASTATIN CALCIUM, covering 2009-03-25 to 2026-08-17. Get the full timeline:

Most recent: FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)

See pricing